{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:51:48Z","timestamp":1792853508858,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023368","name":"Eisai Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023368","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejphar.2024.176544","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:13:44Z","timestamp":1711512824000},"page":"176544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Involvement of ferroptosis in eribulin-induced cytotoxicity in ovarian clear cell carcinoma"],"prefix":"10.1016","volume":"971","author":[{"given":"Mana","family":"Azumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9120-0475","authenticated-orcid":false,"given":"Kazuya","family":"Kusama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikihiro","family":"Yoshie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saya","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuya","family":"Tsuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3351-895X","authenticated-orcid":false,"given":"Kazuhiro","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176544_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade9585","article-title":"NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8","volume":"9","author":"Anandhan","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2024.176544_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202100641","article-title":"Oxidative stress in cancer therapy: friend or Enemy?","volume":"23","author":"Azmanova","year":"2022","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejphar.2024.176544_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jphs.2022.09.006","article-title":"Stathmin expression alters the antiproliferative effect of eribulin in leiomyosarcoma cells","volume":"150","author":"Azumi","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2024.176544_bib4","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1248\/bpb.b22-00251","article-title":"The impact of eribulin on stathmin dynamics and paclitaxel sensitivity in ovarian cancer cells","volume":"45","author":"Azumi","year":"2022","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2024.176544_bib5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2008.02.006","article-title":"Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers","volume":"109","author":"Chan","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejphar.2024.176544_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3892\/ijo.2016.3514","article-title":"Ophiopogonin B induces apoptosis, mitotic catastrophe and autophagy in A549 cells","volume":"49","author":"Chen","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2024.176544_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bcp.2017.12.022","article-title":"Opening of voltage dependent anion channels promotes reactive oxygen species generation, mitochondrial dysfunction and cell death in cancer cells","volume":"148","author":"DeHart","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176544_bib8","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.176544_bib9","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-14-3252","article-title":"Eribulin mesylate: mechanism of action of a unique microtubule-targeting agent","volume":"21","author":"Dybdal-Hargreaves","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2024.176544_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13691-018-0350-1","article-title":"Uterine leiomyosarcoma well-controlled with eribulin mesylate","volume":"8","author":"Fujimoto","year":"2019","journal-title":"Int Cancer Conf J"},{"key":"10.1016\/j.ejphar.2024.176544_bib11","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/cas.12488","article-title":"Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models","volume":"105","author":"Funahashi","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejphar.2024.176544_bib12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","article-title":"Role of mitochondria in ferroptosis","volume":"73","author":"Gao","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2024.176544_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/gyno.1995.1097","article-title":"Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties","volume":"57","author":"Gorai","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejphar.2024.176544_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/15384101.2020.1716144","article-title":"The microtubule targeting agents eribulin and paclitaxel activate similar signaling pathways and induce cell death predominantly in a caspase-independent manner","volume":"19","author":"H\u00fcsemann","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2024.176544_bib15","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2024.176544_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411781","article-title":"Mechanism of cell death by combined treatment with an xCT inhibitor and paclitaxel: an alternative therapeutic strategy for patients with ovarian clear cell carcinoma","volume":"24","author":"Idei","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176544_bib17","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1111\/cas.15125","article-title":"PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinoma","volume":"112","author":"Kitamura","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejphar.2024.176544_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2024.176544_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41401-020-0443-1","article-title":"NRF2-GPX4\/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells","volume":"42","author":"Ma","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2024.176544_bib20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.176544_bib21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.bbrc.2020.04.127","article-title":"Identification of the hallmarks of necroptosis and ferroptosis by transmission electron microscopy","volume":"527","author":"Miyake","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2024.176544_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/ijms22010412","article-title":"TUNEL Assay: a powerful tool for kidney injury evaluation","volume":"22","author":"Moore","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176544_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2024.176544_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1478-3231.2006.01278.x","article-title":"Radio-frequency ablation of hepatocellular carcinoma before liver transplantation: a histologic and \u2018TUNEL\u2019 study","volume":"26","author":"Netto","year":"2006","journal-title":"Liver Int."},{"key":"10.1016\/j.ejphar.2024.176544_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.752127","article-title":"Generation of two paclitaxel-resistant high-grade serous carcinoma cell lines with increased expression of p-glycoprotein","volume":"11","author":"Nunes","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2024.176544_bib26","doi-asserted-by":"crossref","first-page":"70011","DOI":"10.18632\/oncotarget.11727","article-title":"ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines","volume":"7","author":"Oba","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2024.176544_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.freeradbiomed.2019.03.016","article-title":"Redox lipidomics to better understand brain aging and function","volume":"144","author":"Pamplona","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2024.176544_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101947","article-title":"NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases","volume":"41","author":"Park","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2024.176544_bib29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/gerona\/62.9.932","article-title":"Reduction in glutathione peroxidase 4 increases life span through increased sensitivity to apoptosis","volume":"62","author":"Ran","year":"2007","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.ejphar.2024.176544_bib30","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.21037\/atm-20-3022a","article-title":"Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets\u2014a narrative review","volume":"8","author":"Samartzis","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejphar.2024.176544_bib31","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41598-018-19213-4","article-title":"The ferroptosis inducer erastin irreversibly inhibits system xc\u2212 and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells","volume":"8","author":"Sato","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.176544_bib32","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/bi901810u","article-title":"Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability","volume":"49","author":"Smith","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2024.176544_bib33","doi-asserted-by":"crossref","first-page":"19395","DOI":"10.1074\/jbc.RA119.010949","article-title":"Pannexin 1 mediates ferroptosis that contributes to renal ischemia\/reperfusion injury","volume":"294","author":"Su","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176544_bib34","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","article-title":"Clinical characteristics of clear cell carcinoma of the ovary","volume":"88","author":"Sugiyama","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2024.176544_bib35","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fonc.2019.00754","article-title":"SIRT5 promotes cisplatin resistance in ovarian cancer by suppressing DNA damage in a ROS-dependent manner via regulation of the Nrf2\/HO-1 pathway","volume":"9","author":"Sun","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2024.176544_bib36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176544_bib37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/antiox11040663","article-title":"Role of NRF2 in ovarian cancer","volume":"11","author":"Tossetta","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2024.176544_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","article-title":"Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges","volume":"524","author":"Tsikas","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2024.176544_bib47","doi-asserted-by":"crossref","first-page":"7675","DOI":"10.1074\/jbc.M111.335174","article-title":"Glutathione peroxidase 4 is required for maturation of photoreceptor cells","volume":"287","author":"Ueta","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176544_bib39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nature05859","article-title":"RAS\u2013RAF\u2013MEK-dependent oxidative cell death involving voltage-dependent anion channels","volume":"447","author":"Yagoda","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.176544_bib40","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.3802\/jgo.2017.28.e32","article-title":"Clinical statistics of gynecologic cancers in Japan","volume":"28","author":"Yamagami","year":"2017","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ejphar.2024.176544_bib41","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/14728222.2021.2011206","article-title":"The mechanisms and therapeutic targets of ferroptosis in cancer","volume":"25","author":"Ye","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2024.176544_bib42","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/bjc.2014.80","article-title":"Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states","volume":"110","author":"Yoshida","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2024.176544_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.786","article-title":"Stathmin dynamics modulate the activity of eribulin in breast cancer cells","volume":"9","author":"Yoshie","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.ejphar.2024.176544_bib44","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1093\/humrep\/deq190","article-title":"Possible role of the exchange protein directly activated by cyclic AMP (Epac) in the cyclic AMP-dependent functional differentiation and syncytialization of human placental BeWo cells","volume":"25","author":"Yoshie","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejphar.2024.176544_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101211","article-title":"Ferroptosis is governed by differential regulation of transcription in liver cancer","volume":"24","author":"Zhang","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2024.176544_bib46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","article-title":"On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death","volume":"3","author":"Zilka","year":"2017","journal-title":"ACS Cent. Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924002322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924002322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T20:27:40Z","timestamp":1714076860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924002322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":47,"alternative-id":["S0014299924002322"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176544","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of ferroptosis in eribulin-induced cytotoxicity in ovarian clear cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176544"}}